R
Richard Jon Davis
Researcher at University of Hertfordshire
Publications - 6
Citations - 63
Richard Jon Davis is an academic researcher from University of Hertfordshire. The author has contributed to research in topics: Secretin & Virtual screening. The author has an hindex of 5, co-authored 6 publications receiving 60 citations.
Papers
More filters
Journal ArticleDOI
Expression and Functions of the Duodenal Peptide Secretin and its Receptor in Human Lung
Richard Jon Davis,Keith John Page,Gabriela J. Dos Santos Cruz,Dan W. Harmer,Peter W. Munday,Sandra J. Williams,Joanna Picot,Thomas J. Evans,Robert L G Sheldrick,Robert A. Coleman,Kenneth Lyle Clark +10 more
TL;DR: It is demonstrated that secretin receptors are present in human lung, and that activation of these receptors with human secretin potently stimulates concentration-dependent Cl- efflux from bronchial epithelial cells and bronchorelaxation.
Journal ArticleDOI
User error or computer error? Observations on a statistics package
TL;DR: The shortcomings of the interaction were pinpointed by various error classifications and the use of an expert's macro-command facility by a casual user is discussed, highlighting the problems of changing existing interfaces.
Patent
Furan derivatives as ep4 receptor antagonists
David Edward Argenta Discovery Limited Clark,Neil Victor Argenta Discovery Limited Harris,Garry Argenta Discovery Limited Fenton,George Hynd,Keith A. J. Argenta Discovery Limited Stuttle,Jonathan Mark Sutton,Alexander William Oxford,Richard Jon Davis,R.A. Coleman,Kenneth Lyle Clark +9 more
TL;DR: A compound of formula: (I); or a salt, solvate and chemically protected form thereof, wherein one of R2 and R5 is: (i) H or an optionally substituted C1-4 alkyl group; or (ii) C5-7 aryl; and the other of R 2 and R 5 is the other group as discussed by the authors.
Journal ArticleDOI
Task analysis and user errors: a methodology for assessing interactions
TL;DR: The match/mismatch between user's goals and the implementation requirements of the computer system at various levels of analysis are described, and the mismatch boundaries are discussed.
Journal ArticleDOI
From virtual to clinical: The discovery of PGN-1531, a novel antagonist of the prostanoid EP4 receptor.
Jon Sutton,David E. Clark,Christopher Higgs,Marcel J. de Groot,Neil Victor Harris,Andrea Taylor,Peter Lockey,Karen Maubach,Amanda J. Woodrooffe,Richard Jon Davis,R.A. Coleman,Kenneth Lyle Clark +11 more
TL;DR: PGN-1531 is a potent and selective antagonist at EP4Rs in vitro and in vivo, with the potential to alleviate the symptoms of migraine that result from cerebral vasodilatation.